Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Asset Management Companies - Positive trends to support Q1FY22 earnings - ICICI Securities

Posted On: 2021-07-18 06:24:28 (Time Zone: UTC)


Asset management plays will benefit from the improving equity mix for the second successive quarter in Q1FY22. However, the overall average AUM (AAUM) growth remains in low single digits QoQ. Hence, sequential earnings growth will depend more on cost and yields performance. Increase in equity mix has not always translated to higher yields. Yields will also be a critical element for CAMS earnings. Yields were largely stable in FY21 for CAMS, but may decline in FY22 in lieu of AUM growth. At an aggregate level, flows, SIP and NFO data remain positive. In terms of AAUM market share, HDFC AMC witnessed marginal dip in equity and debt market share, NAM's debt AAUM and UTI's equity AAUM market share witnessed improvement.

- Movement in equity market share: Based on AMFI monthly AUM data, HDFC AMC equity AAUM market share declined marginally from 12.8% in Q4FY21 to 12.73% in Q1FY22 (Jun'21 equity AUM stood at 12.65%). NAM equity market share AAUM improved from 6.7% in Q4FY21 to 6.9% in Q1FY22 (Jun'21 equity AUM market share stood at 6.84%). UTI equity AAUM market share improved from 4.6% in Q4FY21 to 4.74% in Q1FY22 (Jun'21 equity AAUM stood at 4.76%).

- Movement in debt market share: Based on AMFI monthly AUM data, HDFC AMC debt AAUM market share dipped marginally to 14.42% in Q1FY22 from 14.37% in Q4FY21 (June'21 debt AUM market share stood at 14.4%). NAM reported gains in its debt AAUM market share. Q1FY22 market share stood at 7.2% vs 6.8% in Q4FY21. (June'21 debt AAUM market share stood at 7.4%). UTI debt market share at 3.89% in Q1FY22 witnessed marginal decline from 3.93% in Q4FY21 (Jun'21 market share stood at 3.8%).

- HDFC AMC earnings estimates: We expect HDFC to report PAT/core PAT of Rs3.6/2.9bn, up 15%/3% in Q1FY22. HDFC AMC QAAUM remained flat sequentially (up 1% QoQ). We have marginally increased overall yields to factor in the increase in equity mix as a result of which revenue is expected to grow 2% QoQ to Rs5bn. We expect total operating expenses to be marginally higher sequentially (mostly due to ESOPs) which will lead to similar performance at operating profit levels.

- NAM earnings estimates: NAM is expected to report PAT/core PAT of Rs1.7bn/1.4bn. NAM AUM grew 5% QoQ which is translating into revenue growth of 5% (we have factored no change in revenue yields QoQ). Operating expenses are expected to decline sequentially as we factor run rate of Rs450mn in other operating expenses and Rs700mn employee cost based on Q1/Q2/Q3FY21 trends. We expect other income to decline in Q1FY22 to Rs473mn because of which PAT is expected to grow by 3%, while core PAT is expected to grow by 13% QoQ.

- UTI earnings estimates: UTI is expected to witness 12% QoQ growth in its core PAT driven by 12% growth in the overall revenue (which includes the impact of rise in investment management fees in its pension subsidiary). Comparative valuations remain attractive for UTI. Any positive cost performance can be a positive trigger.

- CAMS earnings estimate: We added Apr'21-Jun'21 AUM of the AMCs under CAMS to arrive at managed AAUM of Rs22.88bn which has grown 2.6% QoQ. We expect overall revenue to grow 3.2% to Rs2bn. We have factored a decline in equity yields and kept debt yields flat. Operating margins expected to be slightly lower sequentially. We expect CAMS to report PAT of Rs650mn on the back of higher other income

- NFOs have been healthy in 2021: Between Jan'21 and Jun'21, MFs have been able to garner Rs192bn through NFOs of which equity / debt / fund of funds / index fund schemes contributed Rs87bn / Rs46bn / Rs31bn / Rs10bn, respectively. Fund of funds category includes funds that offer international exposure to domestic investors. Within equity, multi cap (Rs19bn), sectoral/thematic (Rs48bn) and focused funds (Rs6.8bn) saw maximum fund mobilisation.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Godrej Properties - Positives priced in - HDFC Securities

Maintain ADD on Dabur - Outperformance continues; strategies playing out - HDFC Securities

Orient Cement - On a strong footing - HDFC Securities

Kajaria Ceramics - Cost controls cushion margin hit - HDFC Securities

Maintain REDUCE on Emami - Sustaining expectation; margin base to impact FY22 - HDFC Securities

Bharti Airtel - Earnings Update - Inline - YES Securities

Tata Consumer - Q1 FY22 result first cut - YES Securities

Dabur India Ltd - Q1 FY22 Result Report - YES Securities

Castrol India Ltd - Q2 CY21 Result Report - YES Securities

Sunteck Realty Ltd - Q1 FY22 Result Report - YES Securities

Top brokerage houses have given 'subscribe' rating for Windlas Biotech Ltd IPO

Maintain BUY on Cholamandalam Investment and Finance Company - HDFC Securities

Maintain REDUCE on Britannia Industries - Beat on revenue; in-line EBITDA - HDFC Securities

Aditya Birla Fashion and Retail - Recovery better than expected - HDFC Securities

Vinati Organics Limited - High input costs dent margins - HDFC Securities

Q1FY22 Result Update - Colgate-Palmolive (India) - ICICI Direct

Q1FY22 Result Update - Tech Mahindra - ICICI Direct

Q1FY22 Result Update - Gateway Distriparks - ICICI Direct

Q1FY22 Result Update - Filatex India - ICICI Direct

Q1FY22 Result Update - KPR Mill - ICICI Direct

Q1FY22 Company Update - Mahindra Lifespace Developers - ICICI Direct

Maintain ADD on V-Guard Industries - Loss of peak season sales, state mix impact the show - HDFC Securities

Maintain REDUCE on RBL Bank - The pitfalls of 'banking' on a single engine - HDFC Securities

Maintain BUY on NTPC - Asset monetisation on the cards - HDFC Securities

Krsnaa Diagnostics Ltd. - IPO - Heathy Business Outlook with Sound OCF - Reliance Research

KEC International - Muted performance - HDFC Securities

Maintain BUY on Kansai Nerolac - GM pressure palpable - HDFC Securities

Auto Sector - July 2021 Sales - Acuité Ratings & Research

Indian Oil Corporation - Muted performance - HDFC Securities

Cholamandalam Investment & Finance - Q1 FY22 Result Report - YES Securities

HDFC Limited - Q1 FY22 Result Report - YES Securities

RBL Bank - Q1FY22 Result Update - YES Securities

Oberoi Realty Ltd - Q1 FY22 Result Report - YES Securities

Emami Ltd - Q1 FY22 Result Report - YES Securities

Britannia Industries - Q1 FY22 Result Report - YES Securities

Indian Oil Corp. Ltd - Q1FY22 Result Report - YES Securities

Container Corporation - Good results; ICD Khatuwas now connected to DFC - HDFC Securities

Maintain ADD on Marico - Food remains a showstopper; expect margin recovery - HDFC Securities

Maintain REDUCE on LIC Housing Finance - It's all going pear-shaped - HDFC Securities

JSW Energy - Adj PAT in line, but valuation remains stretched - HDFC Securities

JK Lakshmi Cement - Q1 hit by lower sales and fuel inflation; outlook bright - HDFC Securities

Upgrade to BUY on Sun Pharma - Strong beat, encouraging trends in specialty - HDFC Securities

Maintain ADD on Shriram Transport Finance Company - Cumulative stress on par with bellwether peer - HDFC Securities

EXIDE 1QFY22 - first cut - Weak margins drag PAT - Not rated - YES Securities

IOCL - 1QFY22 earnings update - YES Securities

Dr Lal PathLabs - Q1 FY22 first cut - Beat across the board - YES Securities

Chola Q1 FY22 first take - Strong PPOP show, but dejects on asset quality - YES Securities

Britannia - Q1 FY22 results first cut - YES Securities

Shriram City Union Finance Ltd - Q1 FY22 Call Highlights (Not Rated) - YES Securities

Sun Pharma - Q1 FY22 Result Report - YES Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020